Skip to main content

Table 4 Bivariate analysis of variables collected during the ICU stay influencing the outcome, at ICU discharge, of pneumococcal CAP*

From: Severe pneumococcal pneumonia: impact of new quinolones on prognosis

Variables Survivors n = 44 Non survivors n = 26 p
Use of hydrocortisone 12 (27.3%) 12 (46.2%) 0.1
Intensive insulin therapy 18 (40.9%) 12 (46.2%) 0.66
Haemodialysis 6 (13.6%) 4 (15.4%) 0.1
Improvement on D3 36 (81.8%) 7 (26.9%) <0.0001
SOFA >8 on D3 9 (20.5%) 14 (53.8%) <0.0001
SOFA >8 on D5 10 (22.7%) 14 (53.8%) 0.0001
SOFA >8 on D7 10 (22.7%) 13 (50%) 0.009
Sepsis-related complications 14 (31.8%) 17 (65.4%) 0.006
HA-LRT superinfections 8 (18.2%) 9 (34.6%) 0.12
  1. *Data are presented as No. (%)
  2. SOFA: Sepsis-related Organ Failure Assessment score; HA-LRT superinfections: hospital-acquired lower respiratory tract superinfections.